GPT and metabolic dysfunction-associated steatotic liver disease: Many studies have reported the benefits of synbiotics in treating MASLD, such as improved liver steatosis levels, reduced liver inflammation, and improved alanine aminotransferase (ALT) parameters (111, 112).